4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily)

Annals of Oncology

Volumn 18, Issue SUPPL. 6, 2007, Pages

  Russo, Antonio ^a   Calo V ^a   Augello, C ^a   Bruno, L ^a   Agnese, V ^a   Schiro V ^a   Barbera, F ^a   Cascio, S ^a   Foddai, E ^a   Badalamenti, G ^a   Intrivici, C ^a   Cajozzo, M ^a   Gulotta, G ^a   Surmacz, E ^b   Colucci, G ^c   Gebbia, N ^a   Bazan, V ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Temple University   (United States)

^c NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

BRCA1 gene; Founder mutation; Genetic counseling; Haplotype analysis; Haplotype frequency

Indexed keywords

BRCA1 PROTEIN; MICROSATELLITE DNA;

BREAST CANCER; CONFERENCE PAPER; CONTROLLED STUDY; ETHNIC GROUP; FAMILY HISTORY; FOUNDER EFFECT; GENE FREQUENCY; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HUMAN; ITALY; MICROSATELLITE MARKER; MUTATIONAL ANALYSIS; OVARY CANCER; PEDIGREE ANALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ARTICLE; BREAST TUMOR; FEMALE; GENE DELETION; GENETICS; MALE; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PEDIGREE; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; FOUNDER EFFECT; GENE DELETION; GENES, BRCA1; HAPLOTYPES; HUMANS; MALE; MICROSATELLITE REPEATS; OVARIAN NEOPLASMS; PEDIGREE; SICILY;

EID: 35748977150     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm235     Document Type: Conference Paper

References (13)

1. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
2. Ford D, Easton DF, Stratton M et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consorbum. Am J Hum Genet 1998; 62: 676-689.
3. Neuhausen SL. Ethnic differences in cancer risk resulting from genetic variation. Cancer 1999; 86: 2575-2582.
4. Struewing JP, Abeliovich D, Perez T et al. The carrier frequency of the BRCA1 185deIAG mutation is a approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995; 11 (2): 198-200.
5. Hodgson SV, Heap E, Cameron J et al. Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer. J Med Genet 1999; 36(5): 369-373.
6. Peelen T, van Vliet M, Petrij-Bosch A et al. A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families. Am J Hum Genet 1997; 60: 1041-1049.
7. Johannsson O, Ostermeyer EA, Hakansson S et al. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet 1996; 58(3): 441-450.
8. Eibengi Z, Bergman A, Kindblom LG et al. A founder mutation of the BRCA1 gene in Western Sweden associated with a high incidence of breast and ovarian cancer. Eur J Cancer 2001; 37(15): 1904-1909.
9. Gayther SA, Harrington P, Russel P et al. Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia. Am J Hum Genet 1997; 60(5): 1239-1242.
10. Caligo MA, Ghimenti C, Cipollini G et al. BRCA1 germline mutation spectrum in Italian families from Tuscany: A high frequency of novel mutations. Oncogene 1996; 13: 1483-1488.
11. Baudi F, Quaresima B, Grandinetti C et al. Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer. Hum Mutat 2001; 18(2): 163-164.
12. Russo A, Calò V, Agnese V et al. BRCA1 genetic testing in 106 breast and ovarian cancer families from Southern Italy (Sicily). A mutation analysis and evidence of founder effects. Breast Cancer Res Treat 2006; In press.
13. Calò V, Agnese V, Gargano G et al. A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. Breast Cancer Res Treat 2006; 96(1): 97-100.